Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs

被引:19
作者
Gaston, M. S. [1 ]
Tiemessen, C. H.
Philips, J. E.
机构
[1] Univ Edinburgh, Royal Edinburgh Infirm, Dept Orthopaed, Edinburgh EH16 4SA, Midlothian, Scotland
[2] Borders Gen Hosp, Dept Orthopaed, Melrose TD6 9BS, Scotland
关键词
hyaluronic acid; Hip; osteoarthritis;
D O I
10.1007/s00402-007-0363-2
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective The aim of this study was to determine the efficacy and safety of viscosupplementation with synthetic hyaluronic acid to the hip joint and to determine if there was any relation to pre-injection radiographic changes of osteoarthritis (OA). Methods Three Suplasyn (TM) injections were performed each to 15 hips with OA. Standing antero-posterior radiographs of the pelvis were performed prior to injection and scored according to Kelgren and Lawrence grades along with recordings of the minimum joint space width. Harris Hip Scores (HHS) which contain a component for pain, function, activities, absence of deformity and range of motion were recorded pre-injection and at 3 and 6 months. Results We established that at 3 months the HHS is significantly higher (P < 0.05). At 6 months, four hips had been excluded as they has went on to total hip arthroplasty (these hips showed a lower HHS at 3 months). For the remaining hips the HHS was highly significantly increased (P < 0.001). No side effects or complications were observed. Analysis of the pre-injection radiographs showed a trend towards a bigger increase in HHS with less radiographic OA changes. Conclusions Viscosupplementation performed under fluoroscopic guidance is an effective and safe method of treating hip OA and appears to be more efficacious in those with less radiographic changes of OA.
引用
收藏
页码:899 / 903
页数:5
相关论文
共 14 条
[1]   THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS OF THE HIP [J].
ALTMAN, R ;
ALARCON, G ;
APPELROUTH, D ;
BLOCH, D ;
BORENSTEIN, D ;
BRANDT, K ;
BROWN, C ;
COOKE, TD ;
DANIEL, W ;
FELDMAN, D ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
IKE, R ;
KAPILA, P ;
KAPLAN, D ;
KOOPMAN, W ;
MARINO, C ;
MCDONALD, E ;
MCSHANE, DJ ;
MEDSGER, T ;
MICHEL, B ;
MURPHY, WA ;
OSIAL, T ;
RAMSEYGOLDMAN, R ;
ROTHSCHILD, B ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1991, 34 (05) :505-514
[2]   Viscosupplementation for the treatment of osteoarthritis of the knee [J].
Bellamy, N. ;
Campbell, J. ;
Robinson, V ;
Gee, T. ;
Bourne, R. ;
Wells, G. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02)
[3]  
Berg P, 2004, CLIN EXP RHEUMATOL, V22, P300
[4]   Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study [J].
Caglar-Yagci, H ;
Unsal, S ;
Yagci, I ;
Dulgeroglu, D ;
Ozel, S .
RHEUMATOLOGY INTERNATIONAL, 2005, 25 (05) :341-344
[5]  
Conrozier T, 2005, CLIN EXP RHEUMATOL, V23, P711
[6]  
Conrozier T, 2003, CLIN EXP RHEUMATOL, V21, P605
[7]   Viscosupplementation for knee osteoarthritis - A systematic review [J].
Divine, Jon G. ;
Zazulak, Bohdanna T. ;
Hewett, Timothy E. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2007, (455) :113-122
[8]   Morphological analysis of articular cartilage biopsies from a randomized. clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan®) and methylprednisolone acetate on primary osteoarthritis of the knee [J].
Guidolin, DD ;
Ronchetti, IP ;
Lini, E ;
Guerra, D ;
Frizziero, L .
OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (04) :371-381
[9]  
Kelly Michael A, 2004, Am J Orthop (Belle Mead NJ), V33, P23
[10]   The reliability of hip scoring systems for total hip arthroplasty candidates: assessment by physical therapists [J].
Kirmit, L ;
Karatosun, V ;
Unver, B ;
Bakirhan, S ;
Sen, A ;
Gocen, Z .
CLINICAL REHABILITATION, 2005, 19 (06) :659-661